(Q52142982)

23 April 2018

title

Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology. (English)

1 reference

23 April 2018

1 reference

2

1 reference

23 April 2018

Adrian Smith

series ordinal

4

1 reference

23 April 2018

Thomas G Beach

series ordinal

1

object named as

Thomas G Beach

1 reference

23 April 2018

Michelle Zanette

3

1 reference

23 April 2018

Christopher Buckley

series ordinal

5

1 reference

23 April 2018

publication date

31 March 2016

1 reference

23 April 2018

Journal of Alzheimer's Disease

published in

1 reference

23 April 2018

volume

52

1 reference

23 April 2018

issue

3

1 reference

23 April 2018

page(s)

863-873

1 reference

23 April 2018

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Amyloid load in nondemented brains correlates with APOE e4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

The cholinergic deficit coincides with Abeta deposition at the earliest histopathologic stages of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly: the preclinical stage of Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Identification of normal and pathological aging in prospectively studied nondemented elderly humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Regional Distribution of Neurofibrillary Tangles and Senile Plaques in the Cerebral Cortex of Elderly Patients: A Quantitative Evaluation of a One-Year Autopsy Population from a Geriatric Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Frequency of stages of Alzheimer-related lesions in different age categories

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

[(18)F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: specific detection of advanced phases of amyloid-β pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Positron emission tomography with [18F]flutemetamol and [11C]PiB for in vivo detection of cerebral cortical amyloid in normal pressure hydrocephalus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

[(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

An in vivo evaluation of cerebral cortical amyloid with [18F]flutemetamol using positron emission tomography compared with parietal biopsy samples in living normal pressure hydrocephalus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-150732

21 January 2018

Identifiers

DOI

10.3233/JAD-150732

1 reference

23 April 2018

release_yekp6bmtangexgk3uvxlymo4ii

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yekp6bmtangexgk3uvxlymo4ii

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

23 April 2018